Company Information

Revenue, expenses and profitability over five years.

Income Statement

KWALITY PHARMACEUTICALS LTD.

NSE Code: KPLEQ
BSE Code: 539997
ISIN: INE552U01010
Industry: Pharmaceuticals

Financial Data

Income Statement

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Five-year standalone Income Statement for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	503.06	370.20	307.08	250.99	456.13
Other Operating Revenues	0.00	0.00	0.09	0.00	0.00
Total Operating Revenues	503.06	370.20	307.17	250.99	456.13

Other Income	2.86	1.92	1.83	2.94	3.51
Total Revenue	505.92	372.12	309.00	253.94	459.64

EXPENSES
Cost Of Materials Consumed	240.81	165.41	153.81	113.22	199.31
Purchase Of Stock-In Trade	17.35	15.90	0.85	0.04	3.80
Changes In Inventories Of FG,WIP And Stock-In Trade	0.28	1.17	-1.48	-3.20	-2.51
Employee Benefit Expenses	54.04	43.76	32.53	29.90	20.09
Finance Costs	10.97	9.88	10.39	6.02	2.92
Depreciation And Amortisation Expenses	19.79	18.26	19.51	14.92	10.64
Other Expenses	72.36	63.51	54.83	50.74	63.72
Total Expenses	415.60	317.89	270.44	211.65	297.97

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	90.32	54.23	38.57	42.29	161.67

Exceptional Items	-0.83	0.00	-7.10	-16.53	0.00
Profit/Loss Before Tax	89.49	54.23	31.47	25.76	161.67

Tax Expenses-Continued Operations
Current Tax	22.15	14.69	7.92	6.48	41.00
Deferred Tax	0.00	-1.59	-0.44	0.14	0.27
Tax For Earlier Years	0.00	1.23	0.00	-0.33	0.35
Total Tax Expenses	22.15	14.34	7.48	6.29	41.63
Profit/Loss After Tax And Before ExtraOrdinary Items	67.35	39.89	23.98	19.47	120.05

Profit/Loss From Continuing Operations	67.35	39.89	23.98	19.47	120.05

Profit/Loss For The Period	67.35	39.89	23.98	19.47	120.05

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	64.90	38.44	23.11	18.45	115.70
Diluted EPS (Rs.)	64.90	38.44	23.11	18.45	115.70

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Dividend Rate (%)	0.00	0.00	0.00	3.00	0.00

Five-year consolidated Income Statement for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	503.08	370.20	307.17	251.03	456.19
Total Operating Revenues	503.08	370.20	307.17	251.03	456.19

Other Income	2.86	1.92	1.83	2.94	3.51
Total Revenue	505.94	372.12	309.00	253.97	459.70

EXPENSES
Cost Of Materials Consumed	240.81	165.41	153.81	113.22	199.31
Purchase Of Stock-In Trade	17.35	15.90	0.85	0.04	3.80
Changes In Inventories Of FG,WIP And Stock-In Trade	0.28	1.17	-1.48	-3.20	-2.51
Employee Benefit Expenses	54.04	43.78	32.56	29.96	20.15
Finance Costs	10.97	9.88	10.39	6.02	2.92
Depreciation And Amortisation Expenses	19.81	18.29	19.56	14.96	10.69
Other Expenses	72.36	63.54	55.11	50.86	63.77
Total Expenses	415.62	317.98	270.80	211.87	298.13

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	90.32	54.14	38.20	42.10	161.57

Exceptional Items	-0.83	0.00	-7.10	-16.53	0.00
Profit/Loss Before Tax	89.49	54.14	31.10	25.57	161.57

Tax Expenses-Continued Operations
Current Tax	22.15	14.69	7.92	6.48	41.00
Deferred Tax	0.00	-1.59	-0.44	0.14	0.27
Tax For Earlier Years	0.00	1.23	0.00	-0.33	0.35
Total Tax Expenses	22.15	14.34	7.48	6.29	41.63
Profit/Loss After Tax And Before ExtraOrdinary Items	67.35	39.80	23.62	19.28	119.94

Profit/Loss From Continuing Operations	67.35	39.80	23.62	19.28	119.94

Profit/Loss For The Period	67.35	39.80	23.62	19.28	119.94

Minority Interest	0.03	0.04	0.18	0.09	0.05
Consolidated Profit/Loss After MI And Associates	67.35	39.85	23.80	19.37	119.99

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	64.90	38.36	22.76	18.16	115.64
Diluted EPS (Rs.)	0.00	38.36	22.76	18.16	115.64

Source: Financial statements as reported by the company.